ALAXIA Information

View Top Employees from ALAXIA

Alaxia is a French private biotech company subsidiary of Stragen developing therapeutic solutions for respiratory diseases based on its proprietary peroxidase platform. The most advanced drug candidate, ALX-009, is an antimicrobial innovative compound aiming at treating cystic fibrosis, including the most resistant bacterial strains

Website	http://www.alaxia-pharma.eu
Revenue	$6.4 million
Employees	11 (2 on RocketReach)
Founded	2008
Address	30 Rue Edouard Nieuport, Lyon, Auvergne-Rhone-Alpes 69008, FR
Phone	+33 4 37 53 26 40
Technologies	JavaScript , HTML , PHP +4 more (view full list)
Industry	Pharmaceuticals, Business Services General, Biotechnology, Antiinfectious, Business Services, Science and Engineering, Antimcrobial, Cystic Fibrosis
Web Rank	23 Million
Keywords	Respiratory Diseases, Biotechnology, Drug Development, Pharmaceutical, Therapeutic Solutions, Biotech, Lung Disease, Pharma, Antimicrobial, Research, Treatment, Clinical Trials, Health, Healthcare, Private Equity
Competitors	AstraZeneca, Bristol Myers Squibb, Merck & Co., Inc., Pfizer, Novartis, Roche, Sanofi, Gilead Sciences, Amgen, Lilly India +46 more (view full list)
SIC	SIC Code 87 Companies, SIC Code 873 Companies
NAICS	NAICS Code 541 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 541713 Companies